AAAAAA

   
Results: 1-16 |
Results: 16
CLOPIDOGREL ACTIVITIES IN PATIENTS WITH RENAL-FUNCTION IMPAIRMENT
Authors: DERAY G BAGNIS C BROUARD R NECCIARI J LEENHARDT AF RAYMOND F BAUMELOU A
Citation: G. Deray et al., CLOPIDOGREL ACTIVITIES IN PATIENTS WITH RENAL-FUNCTION IMPAIRMENT, Clinical drug investigation, 16(4), 1998, pp. 319-328
MOLECULAR ANALYSIS OF GLOMERULAR-DISEASES IN RENAL BIOPSIES - INITIALRESULTS OF A COLLABORATIVE INTERNATIONAL STUDY
Authors: ESPOSITO C STRIKER LJ PATEL A PETEN E LIU ZH SAKAI H STRIKER GE YANG CW HIRSHMANN G SCHENA P GESUALDO T FELD L WAZ W HUANG CC LAI PC HUANG JY LEWIS E ORLOWSKI J KOIDE H HORIKOSHI S DAMICO G FORNASIERI A DIMARIO U FUIANO G LI L FENG Z JACOBS C BEAUFILS H JOUANNEAU C BAUMELOU A ARAKAWA M NISHI S UENO M SRAER JD MIGNON F RONCO P MOUGENOT B RONDEAU E PERALDI MN DELARUE F YAGAME M SUZUKI D DESTRIHOU CV PIRSON Y COSYNS JP GARBAR C JACOBSON H FOGO A CHEVALIER R NORWOOD VF THORNHILL B EMANCIPATOR S RAO C ADLER S BEAUMONT PM HIRSCHBERG R NAST C COHEN A MOORE J CAROME MA SRINSKY JJ
Citation: C. Esposito et al., MOLECULAR ANALYSIS OF GLOMERULAR-DISEASES IN RENAL BIOPSIES - INITIALRESULTS OF A COLLABORATIVE INTERNATIONAL STUDY, Proceedings of the Association of American Physicians, 108(3), 1996, pp. 209-217
DOSE-ANTICOAGULANT EFFECT RELATIONSHIP OF REVIPARINE DURING THE DIALYSIS SESSION
Authors: REACH I LUONG N CHAKROUN M SORIA J DESMICHELS D CHASTANG C BAUMELOU A
Citation: I. Reach et al., DOSE-ANTICOAGULANT EFFECT RELATIONSHIP OF REVIPARINE DURING THE DIALYSIS SESSION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 854-854
MONTHLY INTRAVENOUS PULSE CYCLOPHOSPHAMIDE THERAPY IN WEGENERS GRANULOMATOSIS
Authors: HUONG DLT PAPO T PIETTE JC WECHSLER B BLETRY O LAMAS G BAUMELOU A LEHOANG P PENNAFORTE JL VALCKE JC GODEAU P
Citation: Dlt. Huong et al., MONTHLY INTRAVENOUS PULSE CYCLOPHOSPHAMIDE THERAPY IN WEGENERS GRANULOMATOSIS, Clinical and experimental rheumatology, 14(1), 1996, pp. 9-16
SAFETY AND ACTIVITY OF CLOPIDOGREL, AN ANTIPLATELET AGENT, IN CHRONIC-RENAL-FAILURE PATIENTS
Authors: DERAY G BROUARD R BAGNIS C LEENHARDT AF KINDERMANS M RAYMOND F BAUMELOU A JACOBS C
Citation: G. Deray et al., SAFETY AND ACTIVITY OF CLOPIDOGREL, AN ANTIPLATELET AGENT, IN CHRONIC-RENAL-FAILURE PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 384-384
LONG-TERM NEPHROTOXICITY OF LOW-DOSES OF CYCLOSPORINE IN HEART-TRANSPLANT RECIPIENTS
Authors: BENHMIDA M BAUMELOU A DESRUESNNES M CABROL A PAVIE A GRANDJBAKHCH I CABROL C
Citation: M. Benhmida et al., LONG-TERM NEPHROTOXICITY OF LOW-DOSES OF CYCLOSPORINE IN HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(5), 1995, pp. 2725-2727
RENAL INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: HUONG DLT WECHSLER B PIETTE JC BLETRY O BEAUFILS H BAUMELOU A GODEAU P
Citation: Dlt. Huong et al., RENAL INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 38(9), 1995, pp. 410-410
PEFLOXACIN AS FIRST-LINE TREATMENT IN NEPHROTIC SYNDROME
Authors: GINSBURG C TOLEDANO D DERAY G VLASSOPOULOS D BAUMELOU A JACOBS C
Citation: C. Ginsburg et al., PEFLOXACIN AS FIRST-LINE TREATMENT IN NEPHROTIC SYNDROME, Nephrology, dialysis, transplantation, 9(3), 1994, pp. 335-335
MEDICAL NEPHRECTOMY WITH CSA AND ANGIOTENSIN-II IN A CASE OF LIFE-THREATENING MEMBRANOUS GLOMERULONEPHRITIS
Authors: RIEU P FAUCHER C BAUMELOU A DERAY G BLETRY O GODEAU P JACOBS C
Citation: P. Rieu et al., MEDICAL NEPHRECTOMY WITH CSA AND ANGIOTENSIN-II IN A CASE OF LIFE-THREATENING MEMBRANOUS GLOMERULONEPHRITIS, Nephrology, dialysis, transplantation, 9(1), 1994, pp. 83-84
METHODOLOGY AND EVALUATION OF BLOOD-PRESS URE VARIABILITY
Authors: ELGHOZI JL ELKIK F BAUMELOU A CLOARECBLANCHARD L COPIE X DUBAR M DUTREYDUPAGNE C FOUCHARD M FUNCKBRENTANO C LAURENT S SASSARD J SICHE JP TABONE X VAISSE B VARLAN E
Citation: Jl. Elghozi et al., METHODOLOGY AND EVALUATION OF BLOOD-PRESS URE VARIABILITY, Therapie, 49(3), 1994, pp. 261-266
PHARMACOKINETICS OF A LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARINE) IN HEMODIALYZED PATIENTS
Authors: BAUMELOU A SINGLAS E PETITCLERC T DESMICHELS D JACOBS C SORIA J
Citation: A. Baumelou et al., PHARMACOKINETICS OF A LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARINE) IN HEMODIALYZED PATIENTS, Nephron, 68(2), 1994, pp. 202-206
ELECTROPHORETIC STUDY OF THE PHYSICOCHEMICAL CHARACTERISTICS OF BENCE-JONES PROTEINURIA AND ITS ASSOCIATION WITH KIDNEY DAMAGE
Authors: DIEMERT MC MUSSET L GAILLARD O ESCOLANO S BAUMELOU A ROUSSELET F GALLI J
Citation: Mc. Diemert et al., ELECTROPHORETIC STUDY OF THE PHYSICOCHEMICAL CHARACTERISTICS OF BENCE-JONES PROTEINURIA AND ITS ASSOCIATION WITH KIDNEY DAMAGE, Journal of Clinical Pathology, 47(12), 1994, pp. 1090-1097
ELEVATED LIPOPROTEIN-(A) LEVELS IN PRIMARY NEPHROTIC SYNDROME
Authors: FAUCHER C DOUCET C BAUMELOU A CHAPMAN J JACOBS C THILLET J
Citation: C. Faucher et al., ELEVATED LIPOPROTEIN-(A) LEVELS IN PRIMARY NEPHROTIC SYNDROME, American journal of kidney diseases, 22(6), 1993, pp. 808-813
8TH GIENS CLINICAL-PHARMACOLOGY WORKSHOP (GIENS, 19TH AND 20TH OCTOBER 1992) - FOREWORD
Authors: BAUMELOU A
Citation: A. Baumelou, 8TH GIENS CLINICAL-PHARMACOLOGY WORKSHOP (GIENS, 19TH AND 20TH OCTOBER 1992) - FOREWORD, Therapie, 48(4), 1993, pp. 285-285
MECHANISMS, PREDICTION AND PREVENTION OF DRUGS NEPHROTOXICITY
Authors: BRILLET G STEPHAN D IMBS JL ANDREJAK A BAUMELOU A BRIAND Y BRILLET G CARON J CHAUMETRIFFAUD M DERAY G DUBRAY C ESPIE J FRIEDLANDER G GROSSE R HAMEL JD IMBS JL KREFTJAIS C LAGIER G LAVILLE M MERLE L MORIN JP ROSSI A ROTHSCHILD E STEPHAN D TOUTAIN H WINICKI MJ
Citation: G. Brillet et al., MECHANISMS, PREDICTION AND PREVENTION OF DRUGS NEPHROTOXICITY, Therapie, 48(4), 1993, pp. 321-326
TRANSFER OF AUTOLOGOUS HEMOGLOBIN FROM THE PERITONEAL-CAVITY DURING PERITONEAL-DIALYSIS
Authors: BROUARD R TOZER TN BAUMELOU A GAMBERTOGLIO JG
Citation: R. Brouard et al., TRANSFER OF AUTOLOGOUS HEMOGLOBIN FROM THE PERITONEAL-CAVITY DURING PERITONEAL-DIALYSIS, Nephrology, dialysis, transplantation, 7(1), 1992, pp. 57-62
Risultati: 1-16 |